Editor's note:“US Stock Nuggets”Keep up with market trends on a daily basis, gain insight into and sort out popular changes and individual stocks with outstanding gains, provide Niuyou with multi-dimensional investment opportunity references, and help Niuyou seize investment opportunities!
Key focus
1. AI PC fully “shines”!$Microsoft (MSFT.US)$Overnight, the stock price reached a record high, and the weekly line achieved five consecutive increases.
Microsoft held its annual Build Developer Conference, during which Team Copilot was released. The personal intelligent assistant became a team assistant. Microsoft Fabric provides SaaS solutions and Azure AI in real-time, bringing in nearly 50 AI features, including new cutting-edge models and multi-modal functions. Furthermore, during the new product launch, Microsoft officially announced the launch of the new Surface Laptop and Surface Pro tablet equipped with Qualcomm chips, and also announced that Windows 11 PCs equipped with AI technology are scheduled to be launched one after another starting June 18.
2. The stock price has risen five times in a row! British pharmaceutical companies$AstraZeneca (AZN.US)$It rose nearly 3% overnight.
AstraZeneca on Tuesday outlined its goal of introducing 20 new drugs by 2030, and plans to increase overall annual revenue by 75% over the next six years compared to 2023 to reach $80 billion. The program will strengthen its product portfolio in oncology, biopharmaceuticals, and rare diseases.
AstraZeneca's CEO said the company is building an independent Chinese supply chain to avoid being affected by US-China tension. AstraZeneca's goal is to increase sales to 80 billion US dollars by 2030, and he believes that pharmaceutical sales and innovation in China will help the company achieve this goal.
3. The “hypoglycemic magic drug” has been approved in China! Pharmaceutical faucet$Eli Lilly and Co (LLY.US)$Overnight, it rose more than 2% to a new all-time high.
According to the official website of the State Drug Administration, Eli Lilly's GIP/GLP-1 receptor dual agonist tiverpotide has been approved for marketing in China. The indication is blood sugar control in adult type 2 diabetics. The product's much-publicized marketing application for weight loss indications was accepted by the State Drug Administration in August last year.
4. The weekly line has risen six times in a row!$Procter & Gamble (PG.US)$The annual increase was over 16%, and the stock price reached a record high.
P&G Professional has expanded its laundry care product line with the launch of Tide Professional commercial laundry detergent and Downy Professional fabric softener, providing companies with reliable cleaning results once. The launch of Tide Professional and Downy Professional will help companies in various industries manage laundry work more efficiently, save time, and obtain high-quality cleaning results.
1. Innovative US stock giants
II. Innovate individual US stocks
3. List of the rise and fall rates of popular US stocks
Edit/Cynthia